<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B4B67041-2B73-4786-BDA5-20CA8E9BF709"><gtr:id>B4B67041-2B73-4786-BDA5-20CA8E9BF709</gtr:id><gtr:name>University of Kansas</gtr:name><gtr:address><gtr:line1>University of Kansas</gtr:line1><gtr:line4>Lawrence</gtr:line4><gtr:line5>Kansas</gtr:line5><gtr:postCode>KS 66045</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BA2685AB-275C-4612-8454-D90790672A46"><gtr:id>BA2685AB-275C-4612-8454-D90790672A46</gtr:id><gtr:name>York University Canada</gtr:name><gtr:address><gtr:line1>4700 Keele Street</gtr:line1><gtr:line4>Toronto</gtr:line4><gtr:line5>Ontario M3J 1P3</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/44CDAA37-A000-4CC6-B623-C2C78D4F916B"><gtr:id>44CDAA37-A000-4CC6-B623-C2C78D4F916B</gtr:id><gtr:name>MRC Virology Unit</gtr:name><gtr:address><gtr:line1>Glasgow University</gtr:line1><gtr:line2>Church Street</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G11 5JR</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/44CDAA37-A000-4CC6-B623-C2C78D4F916B"><gtr:id>44CDAA37-A000-4CC6-B623-C2C78D4F916B</gtr:id><gtr:name>MRC Virology Unit</gtr:name><gtr:address><gtr:line1>Glasgow University</gtr:line1><gtr:line2>Church Street</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G11 5JR</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B4B67041-2B73-4786-BDA5-20CA8E9BF709"><gtr:id>B4B67041-2B73-4786-BDA5-20CA8E9BF709</gtr:id><gtr:name>University of Kansas</gtr:name><gtr:address><gtr:line1>University of Kansas</gtr:line1><gtr:line4>Lawrence</gtr:line4><gtr:line5>Kansas</gtr:line5><gtr:postCode>KS 66045</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA2685AB-275C-4612-8454-D90790672A46"><gtr:id>BA2685AB-275C-4612-8454-D90790672A46</gtr:id><gtr:name>York University Canada</gtr:name><gtr:address><gtr:line1>4700 Keele Street</gtr:line1><gtr:line4>Toronto</gtr:line4><gtr:line5>Ontario M3J 1P3</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9D211DBE-80C6-4047-B5A2-2CDC1CCD0B2E"><gtr:id>9D211DBE-80C6-4047-B5A2-2CDC1CCD0B2E</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Boutell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A550_1030"><gtr:id>8FC92D11-9E9B-4215-AE1C-9CB392EF2404</gtr:id><gtr:title>The role of ubiquitin and ubiquitin-like proteins during viral infection and host-cell immunity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A550_1030</gtr:grantReference><gtr:abstractText>During infection viruses must evade multiple host defence mechanisms in order to establish a productive infection. These include antibody and cell mediated acquired immunity, interferon regulated innate immunity, and intrinsic cellular immunity. In order to counteract these host defences many viruses have evolved strategies to engage with cellular ubiquitin and ubiquitin-like modification pathways to modulate their intracellular environment in favour of viral replication. This programme of research aims to define how specific viruses engage with components of these pathways in order to design and develop alternative therapeutic intervention strategies. 
Our research has identified unique aspects relating to cellular immune defence and associated viral counter measures. Our current work aims to determine whether these pathways affect other clinically important human viruses, and to establish a platform of biochemical techniques that will facilitate the screening of compounds to inhibit viral counter measures of these pathways.</gtr:abstractText><gtr:technicalSummary>The post-translational modification of proteins by ubiquitin and ubiquitin-related polypeptides regulates many essential cellular processes including protein degradation, transcription, DNA repair and host-cell anti-viral immunity. Consequently, many human viruses have evolved strategies to utilise or suppress these modification pathways in order to enhance their replication, thereby maintaining their presence within the human population. Utilising a variety of techniques; library screening, lentiviral expression, RNAi technologies, in vitro biochemistry and mass spectrometry, the aim of this programme is to identify and biochemically define how human viruses engage with components of these pathways during infection with respect to disarming host-cell anti-viral immunity. This work will provide a platform of biochemistry in order to develop novel strategies for future therapeutic intervention. The lab focuses on three clinically important human viruses: Herpes Simplex virus type-1 (HSV-1), Influenza A virus, and Hepatitis C Virus (HCV).

HSV-1 causes a variety of clinically important diseases, including herpes keratitis and encephalitis, and provides an ideal model system for studying multiple aspects of intracellular immunity in response to DNA virus infection. An important regulator of HSV-1 infection is ICP0, a viral ubiquitin ligase that targets a subset of cellular proteins implicated in anti-viral immune defecne for ubiquitination and proteasome-dependent degradation. Our research aims to identify and characterise the cellular regulators associated with nuclear immunity in response to DNA virus infection, both at a molecular and biochemical level, by virtue of identifying ICP0?s cellular substrates and biochemical specificity. 

Recent progress in our understanding of the molecular mechanisms associated with the regulation of intrinsic immunity in response to HSV-1 infection are also being investigated in during the nuclear replication of RNA viruses, specifically Influenza A virus, in order to determine the specificity of these host defence mechanisms. Influenza virus infection is the leading causative agent associated with acute viral respiratory illnesses and causes significant annual morbidity and mortality within humans.

HCV infection is a leading cause of non-alcohol related liver disease within the UK, including decompensated cirrhosis and hepatocellular carcinoma. HCV induces the re-distribution of intracellular ubiquitin conjugates during infection, a phenotype that is dependent upon viral RNA replication. However, little is known about how HCV engages with components of the ubiquitin-pathway or the functional importance of these interactions with respect to viral replication. This research aims to identify and characterise the role of ubiquitin and ubiquitin-like modifications during HCV infection and their relationship to anti-viral defence.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1231596</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Cancer Sciences</gtr:department><gtr:description>Regulation of BRCA1 E3 ubiquitin ligase activity</gtr:description><gtr:id>BC3F0895-DE11-4C9B-81D9-52BEEFAD01CC</gtr:id><gtr:impact>J. R. Morris*, C. Boutell*, M. Keppler*, R. Densham, D. Weekes, A. Alamshah, L. Butler, Y. Galanty, L. Pangon, T. Kiuchi, T. Ng and E. Solomon. 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462: 886-891 *Joint first authors.</gtr:impact><gtr:outcomeId>fWQnVA4kyGD-1</gtr:outcomeId><gtr:piContribution>Provision of biochemical expertise in the study of BRCA1's E3 ubiquitin ligase activity</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cellular restriction of Influenza virus</gtr:description><gtr:id>81F75D32-7B83-4523-967C-736F6DA1E70C</gtr:id><gtr:impact>multi-disciplinary virology research</gtr:impact><gtr:outcomeId>C4ZgZdudnSQ-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents and expert knowledge within this area of research</gtr:partnerContribution><gtr:piContribution>Provision of reagents to study SUMOylation and ubiquitination during Influenza virus infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kansas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Molecular Biosciences</gtr:department><gtr:description>The role of ICP0 in HSV-1 viral pathogenesis</gtr:description><gtr:id>2937C547-BBD6-46E5-9002-073E5C95DF4A</gtr:id><gtr:impact>1. Boutell, C., R. Everett, J. Hilliard, P. Schaffer, A. Orr, and D. Davido. 2008. Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol 82:10647-56.
2. Smith, M. C., C. Boutell, and D. J. Davido. 2011. HSV-1 ICP0: paving the way for viral replication. Future Virol 6:421-429.</gtr:impact><gtr:outcomeId>eDRASVVn75A-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents and model system for viral pathogenesis</gtr:partnerContribution><gtr:piContribution>Provision of reagents, experimentation and publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Center for Molecular Genetics (CGM)</gtr:department><gtr:description>SUMO modification and centromeres</gtr:description><gtr:id>7A0EE0BE-B9E6-4E64-B91F-A4E459BCC3D0</gtr:id><gtr:impact>Cell biology
Ubiquitin
SUMOylation
Biochemistry</gtr:impact><gtr:outcomeId>UJBSekcjUfe-1</gtr:outcomeId><gtr:partnerContribution>Cell biology analysis</gtr:partnerContribution><gtr:piContribution>biochemical analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Pirbright Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Defining the role of SUMOylation during arbovirus infection</gtr:description><gtr:id>BCD0C676-CFD4-4083-9EB6-D91F57188D51</gtr:id><gtr:impact>Research ongoing. Student selected for national presentation (microbiology society)</gtr:impact><gtr:outcomeId>56def9391967e0.45912159-1</gtr:outcomeId><gtr:partnerContribution>Cloning of cDNAs that express Aedes aegepti SUMOylation enzymes</gtr:partnerContribution><gtr:piContribution>Defining the biochemical activity of host SUMOylation enzymes expressed in Aedes aegepti.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>York University Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>X-ray crystallography studies of the purified ICP0 RING-finger domains from HSV-1 and VZV</gtr:description><gtr:id>780FBD1C-AFE5-4615-9E13-941FE4A17D24</gtr:id><gtr:impact>none</gtr:impact><gtr:outcomeId>56defaa3277c62.82893581-1</gtr:outcomeId><gtr:partnerContribution>Purification of recombinant proteins and X-ray crystallography trials</gtr:partnerContribution><gtr:piContribution>Provision of reagents for the purification of RING-domain containing viral E3 ubiquitin ligases expressed during HSV-1 and VZV infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>Proteomic analysis of virus infected cells</gtr:description><gtr:id>C53F48D7-4F92-4F23-BB05-902693DBBD61</gtr:id><gtr:impact>Antrobus, R., K. Grant, B. Gangadharan, D. Chittenden, R. D. Everett, N. Zitzmann, and C. Boutell. 2009. Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome. Proteomics 9:3913-27.

Antrobus, R., and C. Boutell. 2008. Identification of a novel higher molecular weight isoform of USP7/HAUSP that interacts with the Herpes simplex virus type-1 immediate early protein ICP0. Virus Res 137:64-71.</gtr:impact><gtr:outcomeId>R5xoVPF7dEt-1</gtr:outcomeId><gtr:partnerContribution>Provision of expert proteomic analysis</gtr:partnerContribution><gtr:piContribution>Provision of samples for proteomic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's Hospital of Philadelphia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Center for Cellular and Molecular Therapeutics</gtr:department><gtr:description>Regulation of the DNA damage response during viral infection</gtr:description><gtr:id>3EDBB10A-20C2-4284-8A2A-FA6B4126A4A0</gtr:id><gtr:impact>See assoc. publications list</gtr:impact><gtr:outcomeId>kmmWhDDHqLe-1</gtr:outcomeId><gtr:partnerContribution>Providing a detailed understanding of DNA repair mechanisms initiated in response to infection</gtr:partnerContribution><gtr:piContribution>Provision of biochemical expertise in the study of viral ubiquitin ligases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Scientific consultant for BBC</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DC3754BE-9762-4E8D-BBC8-C3776AFB84F2</gtr:id><gtr:impact>Scientific consultant for a BBC public engagement program explaining the cause of cold sores</gtr:impact><gtr:outcomeId>58c96666e090d8.59612615</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PCR workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>82E89E9F-1DEA-4735-AE13-A8139A80ED28</gtr:id><gtr:impact>Since 2006, this activity has been delivered to more than 700 Scottish high school students. The teaching resources developed have been adopted by Learning Teaching Scotland to teach higher biology. Workshop has been praised in an HMIE report. Evaluation student feedback is very positive each year.

Our PCR workshop run in partnership with Glasgow Science Centre is a flagship/exemplar activity in high-school education. The PCR workshop has been cited by HMiE as an example of excellence. School pupils from all over Scotland travel to Glasgow to participate.</gtr:impact><gtr:outcomeId>Aaf1PpqRpB5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Glasgow Virology Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>279DA45D-9597-4F0F-BA27-F8FC75CFBC20</gtr:id><gtr:impact>This annual one day meeting aims to encourage interactions between virologists within Scotland and across the UK. It is usually very well attended (over 200 delegates last year), with groups from Glasgow, Edinburgh, St. Andrews, Dundee, Leeds, as well as other universities from around the UK. We attract a diverse audience, including local biotechnology companies, professional peers, undergraduates, and post-graduate students.</gtr:impact><gtr:outcomeId>56deff3cf127d0.18758421</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/researchinstitutes/iii/cvr/events/headline_430158_en.html</gtr:url><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>King Abdulaziz University Scholarship scheme</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>King Abdulaziz University</gtr:fundingOrg><gtr:id>13CBFF31-23A2-4C31-A160-428E6B6CE763</gtr:id><gtr:outcomeId>54634d797aada2.85259503</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Prescilla Ann Schaffer Lecture Award.</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>International Herpesvirus Workshop</gtr:fundingOrg><gtr:id>6B5FA2E6-1482-4831-B7A1-7C493F6A249D</gtr:id><gtr:outcomeId>546350464662e4.04633392</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ISSF Univeristy of Glasgow polyomics funding scheme</gtr:description><gtr:fundingOrg>University of Glasgow</gtr:fundingOrg><gtr:id>82EE3B0D-569F-4EF6-8A73-B88DE2EE890E</gtr:id><gtr:outcomeId>58c9707dec2a96.54559067</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC DTP PhD studentship</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>6762869E-5CB7-4087-9DD4-BDFCBAE5AB7A</gtr:id><gtr:outcomeId>56defb8bb84c31.02540860</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The cloning, expression, and purification of various proteins implicated in ubiquitin biochemistry.</gtr:description><gtr:id>C4DEB6AB-205B-4348-A3CA-61B0E9FACC88</gtr:id><gtr:impact>1. Lilley, C. E., M. S. Chaurushiya, C. Boutell, S. Landry, J. Suh, S. Panier, R. D. Everett, G. S. Stewart, D. Durocher, and M. D. Weitzman. 2010. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. Embo J 29:943-55.
2. Morris, J. R., C. Boutell, M. Keppler, R. Densham, D. Weekes, A. Alamshah, L. Butler, Y. Galanty, L. Pangon, T. Kiuchi, T. Ng, and E. Solomon. 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462:886-90.
3. Morris, J. R., L. Pangon, C. Boutell, T. Katagiri, N. H. Keep, and E. Solomon. 2006. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum Mol Genet 15:599-606.</gtr:impact><gtr:outcomeId>hYfpNSYCL9W</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>in vitro ubiquitin biochemsitry</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The cloning, expression, and purification of various proteins implicated in the regulation of SUMOylation.</gtr:description><gtr:id>5165AFCF-B1BA-4602-A425-7487D8030D37</gtr:id><gtr:impact>multiple ongoing collaborations</gtr:impact><gtr:outcomeId>EA7oqfEkg3J</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>in vitro SUMO biochemistry</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Primary cell lines that have been transduced with lentiviral vectors expressing short hairpin RNAs (shRNAs) to deplete components of the SUMO conjugation pathway.</gtr:description><gtr:id>47C5A774-564B-491E-BEAC-988C911293D3</gtr:id><gtr:impact>none currently. Research ongoing.</gtr:impact><gtr:outcomeId>q31u1Vaq6K7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>shRNA lentiviral cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>viral nucleic acid represents a major immune stimulus. However, visualization of viral nucleic acid upon entry to host cells in relation to cellular proteins which mediate immune signalling has been problematic. We have optimized an efficient methodology for labeling viral DNA that has enabled us to detect viral nucleic acid within cells 15 minutes post-infection. This technique will prove extremely valuable in the identification of cellular processes that directly contribute to regulation of host immunity to virus infection.</gtr:description><gtr:id>FC548CB3-E06A-4E00-8BAD-07C92AE26A46</gtr:id><gtr:impact>We are currently writing two manuscripts which describe the use of this technique</gtr:impact><gtr:outcomeId>58c96876d72315.99812853</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>single genome labelling technologies to study virus host-cell interactions</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>ACD3DC69-7F97-435A-BF20-13C458762F94</gtr:id><gtr:title>Depletion of intracellular zinc inhibits the ubiquitin ligase activity of viral regulatory protein ICP0 and restricts herpes simplex virus 1 replication in cell culture.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48a40c82063dd8cd5407919f835a0d8b"><gtr:id>48a40c82063dd8cd5407919f835a0d8b</gtr:id><gtr:otherNames>Grant K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15232_22_22278229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7641E2E2-D7E7-49B8-9810-545ED42DB398</gtr:id><gtr:title>Regulation of alphaherpesvirus infections by the ICP0 family of proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>doi_15232_0_048900_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EFF9837-1A72-465B-9C46-C4FE083BCB15</gtr:id><gtr:title>Host and viral determinants of Mx2 antiretroviral activity.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee8269c5d5f96af2db3dcc53cf06ab21"><gtr:id>ee8269c5d5f96af2db3dcc53cf06ab21</gtr:id><gtr:otherNames>Busnadiego I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>546237bea85d59.09800284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15AE0D4C-506D-4705-AB7E-02DF3C7F0144</gtr:id><gtr:title>A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>5675e23249b5e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>307A8E33-AFCF-4F26-A6FE-F4D72FFB6006</gtr:id><gtr:title>Interplay between viruses and host sumoylation pathways.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>doi_15232_rmicro3015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD34D79E-6FE1-46F3-9FC8-3B50A866912A</gtr:id><gtr:title>A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0163656c5a6d8dd256ac7fa3d6835c52"><gtr:id>0163656c5a6d8dd256ac7fa3d6835c52</gtr:id><gtr:otherNames>Lilley CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>SRnXX9oj5sQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E4B3626-EFBB-457A-8257-05F76BD60AF0</gtr:id><gtr:title>SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17370cbcd6466978866cd94d29334473"><gtr:id>17370cbcd6466978866cd94d29334473</gtr:id><gtr:otherNames>Cuchet-Louren?o D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>QGTxX6MauAM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C7DBBCC-8907-44E4-9E35-3D6C4AD3A186</gtr:id><gtr:title>A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>Ci5muaKUgbr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F500AF42-F0FD-46C2-B2B5-73C7F42DF0E2</gtr:id><gtr:title>Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94637bff243aa9846abef2209ac3fbd0"><gtr:id>94637bff243aa9846abef2209ac3fbd0</gtr:id><gtr:otherNames>Domingues P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56def40d243e78.24843503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFDA1E8F-ADAF-478C-AC4B-A9B317208CC9</gtr:id><gtr:title>Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58112def9b9e7efed07f0472a59d7545"><gtr:id>58112def9b9e7efed07f0472a59d7545</gtr:id><gtr:otherNames>Vanni E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15232_22_22438555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C1F6E43-9DC8-4716-932D-56AB376169FD</gtr:id><gtr:title>HSV-1 ICP0: paving the way for viral replication.</gtr:title><gtr:parentPublicationTitle>Future virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e74b1308704c7339b6d41cba5915d1ea"><gtr:id>e74b1308704c7339b6d41cba5915d1ea</gtr:id><gtr:otherNames>Smith MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-0794</gtr:issn><gtr:outcomeId>kWXJNz1kjwz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79B9E9D1-88F0-4965-A347-60B3BE9CA615</gtr:id><gtr:title>A systematic analysis of host factors reveals a Med23-interferon-? regulatory axis against herpes simplex virus type 1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>doi_15232_at_1003514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>989FC0AC-2762-479C-8C8C-7FCB2353CF59</gtr:id><gtr:title>SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75a267ef65956748d1b5fdaaa9a2c67"><gtr:id>a75a267ef65956748d1b5fdaaa9a2c67</gtr:id><gtr:otherNames>Brown JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>585d3a83e622f7.93286804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86523640-D221-41AD-A339-376F5355D5E8</gtr:id><gtr:title>Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29575217f255840c58bf9c49825e5b4f"><gtr:id>29575217f255840c58bf9c49825e5b4f</gtr:id><gtr:otherNames>Chaurushiya MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_15232_22_22405594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D958205C-43B0-4E16-90D0-754CEEE14B1D</gtr:id><gtr:title>Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>DDRofKtPvMR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72938089-2C6C-42D8-ADEB-95223B3B1F65</gtr:id><gtr:title>Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73dfc8e0ce67271a53b98f8bb5bb3137"><gtr:id>73dfc8e0ce67271a53b98f8bb5bb3137</gtr:id><gtr:otherNames>Alandijany T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a6619387ab765.80942727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2312CB62-29F2-47B3-955E-625126C7A7C0</gtr:id><gtr:title>The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0163656c5a6d8dd256ac7fa3d6835c52"><gtr:id>0163656c5a6d8dd256ac7fa3d6835c52</gtr:id><gtr:otherNames>Lilley CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>YJsUg5hqzTQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DF7EB0A-5592-4F0B-B7F9-A9A830E48797</gtr:id><gtr:title>Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b5eb3dfb26a6148386a8eaf65bfc338"><gtr:id>8b5eb3dfb26a6148386a8eaf65bfc338</gtr:id><gtr:otherNames>Conn KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56def40cf0cab5.31518211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AEA53AD-A314-427D-BFA8-7855BE7B1D75</gtr:id><gtr:title>Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>546237be83d588.24003051</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A550_1030</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>